Extrahepatic spread from hepatocellular carcinoma: Who are candidates for aggressive anti-cancer treatment?

Japanese Journal of Clinical Oncology

Volumn 34, Issue 12, 2004, Pages 733-739

  Ishii, Hiroshi ^a   Furuse, Junji ^a   Kinoshita, Taira ^a   Konishi, Masaru ^a   Nakagohri, Toshio ^a   Takahashi, Shinichiro ^a   Gotohda, Naoto ^a   Nakachi, Kouhei ^a   Yoshino, Masahiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Ablation; Liver neoplasm; Metastasis; Prognosis; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BRAIN METASTASIS; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SCREENING; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; BONE TUMOR; BRAIN TUMOR; FEMALE; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PATIENT SELECTION; PROGNOSIS;

BONE NEOPLASMS; BRAIN NEOPLASMS; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 14544278996     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyh135     Document Type: Article

References (24)

1. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC Cancer Staging Manual, 6th edn. Springer-Verlag 2002;145-53.
2. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 2nd English edn. Tokyo: Kanehara 2003.
3. Katyal S, Oliver JH 3rd, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000;216:698-703.
4. Okada S, Okazaki N, Nose H, Yoshimori M, Aoki K. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 1992;16:112-7.
5. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35:519-24.
6. Toyoda H, Fukuda Y, Koyama Y, Nishimura D, Hoshino H, Katada N, et al. Case report: multiple systemic lymph node metastases from a small hepatocellular carcinoma. J Gastroenterol Hepatol 1996;11:959-62.
7. Kim SR, Hayashi Y, Matsuoka T, Park SY, Shintani S, Sasaki K, et al. Acase of well-differentiated minute hepatocellular carcinoma with extrahepatic metastasis. J Gastroenterol Hepatol 1998;13:892-6.
8. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996;83:1219-22.
9. Ishii H, Okada S, Okusaka T, Yoshimori M, Nakasuka H, Shimada K, et al. Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1998;82:1638-42.
10. Miki K, Makuuchi M, Takayama T, Matsukura A, Minagawa M, Kubota K, et al. Peritoneal seeding of hepatocellular carcinoma after ethanol injection therapy. Hepatogastroenterology 2000;47:1428-30.
11. Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, et al. Barcelona Clinic Liver Cancer (BCLC) Group: increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124-9.
12. Takayasu K, Muramatsu Y, Moriyama N, Yamazaki S, Kishi K. Surgical treatment of adrenal metastasis following hepatectomy for hepatocellular carcinoma. Jpn J Clin Oncol 1989;19:62-6.
13. Une Y, Misawa K, Shimamura T, Ogasawara K, Masuko Y, Sato N, et al. Treatment of lymph node recurrence in patients with hepatocellular carcinoma. Surg Today 1994;24:606-9.
14. Lam CM, Lo CM, Yuen WK, Liu CL, Fan ST. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg 1998;85:1198-200.
15. Arii S, Monden K, Niwano M, Furutani M, Mon A, Mizumoto M, et al. Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg 1998;5:86-92.
16. Nakayama H, Takayama T, Makuuchi M, Yamasaki S, Kosuge T, Shimada K, et al. Resection of peritoneal metastases from hepatocellular carcinoma. Hepatogastroenterology 1999;46:1049-52.
17. Kurachi K, Suzuki S, Yokoi Y, Okumura T, Inaba K, Igarashi T, et al. A 5-year survivor after resection of peritoneal metastases from pedunculated-type hepatocellular carcinoma. J Gastroenterol 2002;37:571-4.
18. Okusaka T, Okada S, Ishii H, Nose H, Nagahama H, Nakasuka H, et al. Prognosis of hepatocellular carcinoma patients with extrahepatic metastases. Hepatogastroenterology 1997;44:251-7.
19. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
20. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-64.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;63:457-81.
22. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc 1972;34B:187-220.
23. Liver Cancer Study Group of Japan. The 15th report of prognostic analysis in primary liver cancer in Japan (1998-1999). Acta Hepatol Jpn 2003;44:157-75 (in Japanese).
24. Si MS, Amersi F, Golish SR, Ortiz JA, Zaky J, Finklestein D, et al. Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival. Am Surg 2003;69:879-85.